PT1057828E - Suspensoes de trovafloxacina para administracao oral - Google Patents

Suspensoes de trovafloxacina para administracao oral

Info

Publication number
PT1057828E
PT1057828E PT00304550T PT00304550T PT1057828E PT 1057828 E PT1057828 E PT 1057828E PT 00304550 T PT00304550 T PT 00304550T PT 00304550 T PT00304550 T PT 00304550T PT 1057828 E PT1057828 E PT 1057828E
Authority
PT
Portugal
Prior art keywords
oral administration
crystals
trovafloxacine
suspension
novel
Prior art date
Application number
PT00304550T
Other languages
English (en)
Inventor
Douglas John Meldrum Allen
Sojka Sonja Sekulic
Daniel Ray Arenson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PT1057828E publication Critical patent/PT1057828E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
PT00304550T 1999-06-04 2000-05-30 Suspensoes de trovafloxacina para administracao oral PT1057828E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13746399P 1999-06-04 1999-06-04

Publications (1)

Publication Number Publication Date
PT1057828E true PT1057828E (pt) 2003-07-31

Family

ID=22477550

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00304550T PT1057828E (pt) 1999-06-04 2000-05-30 Suspensoes de trovafloxacina para administracao oral

Country Status (10)

Country Link
US (1) US6239141B1 (pt)
EP (1) EP1057828B1 (pt)
JP (1) JP3465820B2 (pt)
AT (1) ATE234835T1 (pt)
BR (1) BR0002577A (pt)
CA (1) CA2311112A1 (pt)
DE (1) DE60001687T2 (pt)
DK (1) DK1057828T3 (pt)
ES (1) ES2194677T3 (pt)
PT (1) PT1057828E (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL148820A0 (en) * 1999-10-08 2002-09-12 Smithkline Beecham Corp Fab i inhibitors
BR0207930A (pt) * 2001-03-05 2004-03-02 Ortho Mcneil Pharm Inc Composições farmacêuticas lìquidas com sabor mascarado
AU2002367773A1 (en) * 2001-04-06 2003-11-03 Affinium Pharmaceuticals, Inc. Fab i inhibitors
US20030068829A1 (en) * 2001-06-25 2003-04-10 Symyx Technologies, Inc. High throughput crystallographic screening of materials
CA2453182A1 (en) * 2001-07-10 2003-01-23 Meredith L. Greene Crystalline thiazine oxazolidinones
EP1419151B1 (en) 2001-08-15 2014-02-26 Pharmacia & Upjohn Company LLC Chrystals including a malic acid salt of n-[2-(diethylamino)ethyl] -5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indole-3-ylidene)methyl] -2,4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof
AU2003220058B2 (en) * 2002-03-12 2008-05-01 Toyama Chemical Company Limited Palatable oral suspension and method
WO2003093322A2 (en) * 2002-04-30 2003-11-13 The Population Council, Inc. Carrageenan based antimicrobial compositions
US8367098B2 (en) * 2002-04-30 2013-02-05 The Population Council, Inc. Unique combinations of antimicrobial compositions
US7790709B2 (en) 2002-12-06 2010-09-07 Affinium Pharmaceuticals, Inc. Heterocyclic compounds, methods of making them and their use in therapy
WO2004082586A2 (en) 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
JP2006528182A (ja) * 2003-07-18 2006-12-14 サンタラス インコーポレイティッド 薬学的製剤および酸に起因する消化器疾患の治療法
PT1828167E (pt) * 2004-06-04 2014-10-08 Debiopharm Int Sa Derivados de acrilamida como agentes antibióticos
WO2007067416A2 (en) * 2005-12-05 2007-06-14 Affinium Pharmaceuticals, Inc. Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
EP2125802A4 (en) 2007-02-16 2014-08-20 Debiopharm Int Sa SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS
RS58898B1 (sr) 2012-06-19 2019-08-30 Debiopharm Int Sa Prolek derivati (e)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-okso-5,6,7,8-tetrahidro-1,8-naftiridin-3-il)akrilamida
LT3419628T (lt) 2016-02-26 2021-01-25 Debiopharm International Sa Medikamentas diabetinėms pėdų infekcijoms gydyti

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5266559A (en) 1989-10-27 1993-11-30 Firmenich S.A. Use of unsaturated macrocyclic lactones as perfuming ingredients
US5391763A (en) 1990-07-11 1995-02-21 Pfizer Inc. 3-aza-bicyclo[3.1.0]hexanes which are intermediates for anti-bacterial azabicyclo quinolone carboxylic acids
TW271400B (pt) 1992-07-30 1996-03-01 Pfizer
US5763454A (en) 1995-06-06 1998-06-09 Pfizer, Inc. Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt
NZ310542A (en) * 1995-08-29 1999-09-29 Pfizer Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin selected from its polymorph, its pseodomorphs and the monohydrate, preparation and pharmaceutical compositions thereof
TR199800339T1 (xx) * 1995-08-29 1998-06-22 Pfizer Inc. Trovafloksasinin melez iyonik bi�imleri.
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids

Also Published As

Publication number Publication date
BR0002577A (pt) 2001-01-02
EP1057828A3 (en) 2001-05-16
DE60001687D1 (de) 2003-04-24
JP3465820B2 (ja) 2003-11-10
CA2311112A1 (en) 2000-12-04
DE60001687T2 (de) 2003-12-18
DK1057828T3 (da) 2003-07-14
EP1057828B1 (en) 2003-03-19
US6239141B1 (en) 2001-05-29
EP1057828A2 (en) 2000-12-06
ES2194677T3 (es) 2003-12-01
JP2000344770A (ja) 2000-12-12
ATE234835T1 (de) 2003-04-15

Similar Documents

Publication Publication Date Title
PT1057828E (pt) Suspensoes de trovafloxacina para administracao oral
IL165715A0 (en) 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
WO2003064431A3 (en) Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
YU62999A (sh) C-4"-supstituisani derivati makrolida
BG101118A (en) Therapeutical compounds
TWI232219B (en) Compounds containing cyclohexane group, process for preparing them and pharmaceutical composition containing them
EP1024145A3 (en) Novel azalides and methods of making same
MA25009A1 (fr) Procede de preparation de composes derives de la piperidine pour la preparation de compositions antibacteriennes
CY1111693T1 (el) Αντιιικοι παραγοντες
TR200100377T2 (tr) Aß Protein üretimi inhibitörleri olarak sukinoilamino laktamlar.
MXPA02011303A (es) Nueva composicion farmaceutica.
YU41500A (sh) Novi makrolidi
EE200200208A (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
TR200102128T2 (tr) Ketolid antibiyotikler
PA8486401A1 (es) Antibioticos cetolidos carbamato y carbazato
AP2001002142A0 (en) 13-membered azalides and their use as antibiotic agents.
HUP0004282A2 (hu) 2-Halogén-6-0-szubsztituált ketolidszármazékok
ATE268337T1 (de) C11-carbamate von antibakteriellen makroliden
DE60208404D1 (de) Kreuzverquerte glycopeptid-cephalosporin-antibiotika
UA66932C2 (en) Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine
MXPA03010259A (es) Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos.
NO20042711L (no) Fremgangsmate for a behandle bakterielle infeksjoner ved anvendelse av gemifloksasin eller et salt derav et betalaktamantibiotikum
CY1106552T1 (el) Ενωσεις ισοχρωμανιου για την θεραπεια ανωμαλιων του κνς
ITMI20021405A0 (it) Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato respiratorio
BR9902049A (pt) Derivados 9a,11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina.